JT Stratford LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,566
Closed -$222K 336
2026
Q1
$222K Buy
2,566
+364
+17% +$34.9K 0.03% 280
2025
Q4
$212K Buy
+2,202
New +$214K 0.03% 289
2020
Q1
Sell
-4,553
Closed -$517K 130
2019
Q4
$517K Sell
4,553
-1,316
-22% -$144K 0.24% 89
2019
Q3
$637K Buy
5,869
+1,712
+41% +$179K 0.36% 76
2019
Q2
$405K Sell
4,157
-2,114
-34% -$193K 0.22% 91
2019
Q1
$571K Sell
6,271
-20,452
-77% -$1.83M 0.33% 70
2018
Q4
$2.43M Sell
26,723
-1,070
-4% -$100K 1.62% 16
2018
Q3
$2.73M Buy
27,793
+283
+1% +$26.2K 1.57% 20
2018
Q2
$2.35M Sell
27,510
-251
-0.9% -$21K 1.45% 27
2018
Q1
$2.23M Buy
27,761
+1,295
+5% +$107K 1.39% 28
2017
Q4
$2.14M Buy
26,466
+15,744
+147% +$1.26M 1.39% 28
2017
Q3
$834K Buy
10,722
+8,206
+326% +$681K 0.54% 46
2017
Q2
$223K Buy
+2,516
New +$212K 0.16% 98

Other funds holding MDT

JT Stratford LLC's MDT Position: Q2 2026 in Review

JT Stratford LLC sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,566 shares — an estimated $222K sold.

JT Stratford LLC first reported a position in MDT in Q2 2017 and held it in 13 quarters. The position peaked at $2.73M in Q3 2018. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • JT Stratford LLC reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • JT Stratford LLC sold 2,566 Medtronic shares in Q2 2026, an estimated $222K.
  • JT Stratford LLC first reported a position in Medtronic in Q2 2017 and held it in 13 quarters.
  • JT Stratford LLC's Medtronic position peaked at $2.73M in Q3 2018.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on JT Stratford LLC's 13F filing for Q2 2026, filed 14 Aug 2026.